This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. climbed 12.1% to $2.13 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.0% to 19,649.95 and the Dow Jones Industrial Average falling 0.5% to 44,368.56.
The stock's rise snapped a four-day losing streak.
Inovio Pharmaceuticals Inc. closed 85.6% below its 52-week high of $14.75, which the company achieved on April 1st.
The stock outperformed some of its competitors, as Johnson & Johnson fell 0.6% to $155.26, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.24% to $25.47.
Trading volume totaled 900,046, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 12, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.